TRIMTECH Therapeutics

Developer of a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic protein aggregates. The company's platform offers oral therapeutics with specific...

Healthcare
Cambridge, United Kingdom
Founded 2023
4 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$31.7M
Last Round
N/A

Get the full picture

Create a free account to unlock TRIMTECH Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required